Blood oxidative status and selectins plasma levels in healthy donors receiving granulocyte-colony stimulating factor

Leukemia

Volumn 20, Issue 8, 2006, Pages 1430-1434

  Cella, G ^a   Marchetti, M ^b   Vignoli, A ^b   Randi, M L ^a   Saggiorato, G ^a   Pasetto, L ^a   Pagnan, A ^a   Barbui, T ^b   Falanga, Anna ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b OSPEDALI RIUNITI   (Italy)

Author keywords

G CSF; Healthy donors; Myeloperoxidase; Nitric oxide; Selectins; Stem cells

Indexed keywords

CD11B ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HYDROPEROXIDE; L SELECTIN; MYELOPEROXIDASE; NITRIC OXIDE; PADGEM PROTEIN; PROTEINASE; REACTIVE OXYGEN METABOLITE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SELECTIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CELL FUNCTION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME RELEASE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOSTASIS; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HYPERCOAGULABILITY; INFLAMMATION; LEUKOCYTE; LEUKOCYTE ACTIVATION; MALE; NORMAL HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; STEM CELL MOBILIZATION; THROMBOCYTE; THROMBOGENESIS;

EID: 33746125350     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404271     Document Type: Article

References (24)

1. Lieschke GJ, Burgess AW. Granulocyte colony-stimulating factor and granulocyte-macrophage colony stimulating factor. New Engl J Med 1992; 327: 99-106.
2. Gabrilove J. The development of granulocyte colony-stimulating factor in its various clinical applications. Blood 1992; 80: 1382-1385.
3. Barbui T, Finazzi G, Grassi A, Marchioli R. Thrombosis in cancer patients treated with hematopoietic growth factors - a meta-analysis. On behalf of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee of the ISTH. Thromb Haemost 1996; 75: 368-371.
4. Falanga A, Marchetti M, Evangelista V, Evangelista V, Manarini S, Oldani E et al. Neutrophil activation and hemostatic changes in healthy donors receiving granulocyte colony-stimulating factor. Blood 1999; 93: 2506-2514.
5. Nathan CF. Respiratory burst in adherent human neutrophils: Triggering by colony-stimulating factors CSF-GM. Blood 1979; 73: 301-306.
6. Sullivan R, Griffin JD, Simons ER, Schafer AI, Meshulam T, Fredette JP et al. Effects of recombinant human granulocyte and macrophage-stimulating factors on signal transduction pathways in human granulocytes. J Immunol 1987; 139: 3422-3430.
7. Ohsaka A, Kitagawa S, Sakamoto S, Miura Y, Takanashi N, Takaku F et al. In vivo activation of human neutrophil functions by administration of recombinant human granulocyte colony-stimulating factor in patients with malignant lymphoma. Blood 1989; 74: 2743-2748.
8. Varani J, Ginsburg I, Schuger L, Gibbs DF, Bromberg J, Johnson KJ et al. Endothelial cell killing by neutrophils. Synergistic interaction of oxygen products and proteases. Am J Pathol 1989; 135: 435-438.
9. Weksler BB, Jaffe EA, Brower MS, Cole OF. Human leukocyte cathepsin G and elastase specifically suppress Thrombin-induced prostacyclin production in human endothelial cells. Blood 1989; 74: 1627-1634.
10. Cesarone MR, Belcaro G, Carratelli M, Cornelli U, De Sanctis MT, Incandela L et al. A simple test to monitor oxidative stress. Int Angiol 1999; 18: 127-130.
11. Ohsaka A, Saijnoi K, Igari J. Granulocyte colony stimulating factor administration increases serum concentrations of soluble selectins. Br J Haematol 1998; 100: 66-69.
12. Walford G, Loscalzo J. Nitric oxide in vascular biology. J Thromb Haemost 2003; 1: 2112-2118.
13. Falanga A, Marchetti M, Evangelista V, Vignoli A, Licini M, Balicco M et al. Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera. Blood 2000; 96: 4261-4266.
14. Eiserich JP, Baldus S, Brennan M-L, Ma W, Zhang C, Tousson A et al. Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 2002; 296: 2391-2394.
15. Wykretowicz A, Dziarmaga M, Szczepanik A, Guzik P, Wysocki H. Prospective evaluation of hydroperoxide plasma levels and stabile nitric oxide end products in patients subjected to angioplasty for coronary artery disease. Int J Cardiol 2003; 89: 173-178.
16. McEver RP. GMP-140, an inducible granule membrane protein of platelets and endothelium. Blood Cells 1990; 16: 73-80.
17. Fijnheer R, Frijns CJM, Korteweg J, Rommes H, Peters JH, Sixma JJ et al. The origin of P-selectin as circulating plasma protein. Thromb Haemost 1997; 77: 1081-1085.
18. Renosto P, Chignard M. Enhancement of cathepsin C-induced platelet activation by leukocyte elastase: Consequence for the-mediated platelet activation. Blood 1993; 82: 139-144.
19. Spertini O, Schleiffenbaum B, White-Owen C, Tedder TF. ELISA for quantification of L-selectin shed from leukocytes in vivo. J Immunol Methods 1992; 156: 115-123.
20. Vij R, Adkins DR, Brown RA, Khoury H, DiPersio JF, Goodnough T. Unstable angina in a peripheral blood stem and progenitor cell donor given granulocyte-colony stimulating factor. Transfusion 1999; 39: 542-543.
21. Leitman SF, Oblitas JM, Bolan CD. Crescendo angina during granulocytapheresis in a G-CSF stimulated donor. Transfusion 2001; 41: 36S.
22. Hill JM, Syed MA, Arai AE, Powell TM, Paul JD, Zalos G et al. Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease. J Am Coll Cardiol 2005; 46: 1643-1648.
23. Fukumoto Y, Miyamoto T, Okamura T, Gondo H, Iwasaki H, Horiuchi T et al. Angina pectoris occurring during granulocyte colony-stimulating factor-combined preparatory regimen for autologous peripheral blood stem cell transplantation in a patient with acute myelogenous leukaemia. Br J Haematol 1997; 9: 666-668.
24. Falanga A, Marchetti M, Vignoli A, Balducci D, Barbui T. Leukocyte-platelet interaction in patients with essential thrombocythemia and polycythemia vera. Exp Hematol 2005; 33: 523-530.